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Advance care planning is a process to help people formulate
and communicate their preferences regarding future medical
care in anticipation of a time when they are unable to express
those preferences because of incapacity due to critical illness
or injury [1,2]. In our current medical system, the result of these
deliberations is generally expressed when the patient prepares
an advance directive. This directive, either oral or written, may
be an attempt to predict and direct care in the event of specific
and unfortunate future situations (e.g. it may pertain to whether
life support should be prolonged) or it may designate a specific
person to speak on the patient’s behalf. The premise of this
process is that when the patient can no longer make decisions,
the physician who is caring for them will be able to use this
directive to guide care that is compatible with the patient’s
unique values and characteristics.
In theory, effective advance care planning should directly
improve the quality of medical care. Most people in the
developed world die at an advanced age after a protracted
chronic illness, more often in an institution after a crisis than
peacefully at home. Without this anticipatory discussion,
medical decisions in the case of patient incapacity must be
made without knowledge of the level of care that the patient
would have preferred. This potentially could result in unfortunate
and costly over- or under-treatment, and conflicts between
health care professionals and the patient’s family and friends.
Reviews of the advance care planning process in its current
ethical, moral and legal form have been disappointing [1,2].
Despite introduction of the Patient Self Determination Act in
the USA in 1990, the majority of patients with chronic
illnesses do not have advance directives in place on
admission to hospital [2]. When they do exist, advance
directives are often difficult for families and physicians to
follow because they may not apply to the situation at hand
[1]. The Study to Understand Prognoses and Preferences for
Outcomes and Risks of Treatments (SUPPORT) trial [3] was
a multicentre attempt to improve end-of-life decision making
and to reduce the frequency of a mechanically supported and
prolonged process of dying by increasing the frequency and
effectiveness of patient–physician communication. However,
despite the best intentions of the clinicians involved, the
introduction of an advance care planning process neither had
an impact on clinical care nor reduced consumption of
hospital resources.
There can be no doubt that care at the end of life is an
important issue. Medical advances are proving to be very
expensive, with the greatest resources spent during the last
6 months of life. During this period, patients are often
subjected to prolonged stays in a critical care unit,
undergoing aggressive interventions of unclear benefit, and
are prescribed many drugs, perhaps with unlicensed
indications. Researchers have shown that aggressive therapy
aimed at prolonging life with little attention given to relief from
suffering and the experience of illness has resulted in
suboptimal care being provided at the end of life [3,4].
Patients and families are suffering because of inadequate
pain and symptom control, inappropriate prolongation of
dying, loss of control, and distance from loved ones caused
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Abstract
Advance care planning is a process to help people to formulate and communicate their preferences
regarding future care during critical illness. Reviews of the advance care planning process in its current
form have been disappointing. Improvements in care at the end of life and palliative care are necessary
for the provision of modern medical care. Medical research has led to many improvements at the
physiological and technological levels. It is only by applying the same rigour of scientific study and
research ethics that improvements in the advance care planning process can be made.
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by the medicalization of dying [5]. Major improvements in
end-of-life care are needed at the clinician, organization and
health system levels.
Perhaps the advance care planning process is too sensitive
and complex a subject for scientific study. Some (albeit fewer
than in the past) wonder whether, ‘[research questions]
should ever be asked by the living of the dying… To research
at all could be … an affront to the dignity of [terminally ill]
people and an expression of profound disrespect for the
emotional and physical state of such patients’ [6]. Research
in advance care planning may be a low priority during critical
and stressful phases of illness; clinicians may not want to
‘bother the patients and their families at such a time’ [7]. The
focus on cure as the only valid goal of medical care may
result in a belief that study participation is only beneficial if it
holds out hope of longer survival; in such a culture, studies
looking to improve the process of a patient’s dying have been
disdainfully referred to as ‘salvage studies’ [8].
In fact, research in this area is exactly what is needed. What
distinguishes modern medical practice is the attempt to
understand disease by the application of rigorous ethical
systematic research to determine what works and what does
not, and to apply it to change clinical practice. We have been
very good at studying and applying physiological and
technological advances in critical illness, changing culture
such that many physicians have come to believe that the only
acceptable therapeutic goal is the absolute cure of the
patient [9]. This belief is inadequate in the face of modern
medical reality. An emerging consensus recognizes that
extension of biological life cannot be the only goal of
medicine; comfort and dignity are appropriate goals when
cure is no longer possible, and should be pursued at
reasonable financial and human costs. Grounded in the
ethical principle of beneficence central to the traditional
medical value of doing what is best for the patient [10], the
increased focus on improvement and quality of end-of-life
care has been called ‘the most important recent advance in
medical ethics’ [5]. Patients with a terminal illness should not
be deprived of the benefits of research; in fact, there is a
great clinical need to improve their care.
The current problem with our understanding of advance care
planning probably represents the complexity inherent in the
process. The domains that we wish to understand represent
new horizons in medical research, and require the
incorporation of nonquantitative research techniques such as
qualitative research and quality-of-life measurement theory.
Unlike history taking, a process that has evolved over decades
and is well taught in medical schools, methods of inquiry for
advance care planning and shared decision-making are just
beginning to be systematically described, studied and taught
[11]. Recent research is suggesting that, for patients,
advance care planning is more than the one-time completion
of a form. Rather, decisions about preferences in advance
care planning emerge from a complex process of preparation
for death, with an emphasis on relationships with loved ones,
maintaining control, and relief from the burden of difficult
decision-making for others, and occurs in the context of not
just the physician–patient relationship but also the relationship
with loved ones [12]. Other research recognizes that,
although patients are individuals, common patient preferences
within disease sites exist that may help providers to
understand disease-specific advance care planning, such as
for heart disease [13] and dialysis patients [14]. In addition,
an emphasis on advance care planning research in the
context of quality improvement rather than strict therapeutic
research may increase acceptance of study in this area.
The only way to improve the advance care planning process is
to study the process and to evolve it in response to this work.
Research will increase the likelihood of solutions being found.
The advance care planning process of the future may be very
different from what it is today. The only way to develop an
effective process is to study it, applying the same rigour to the
research process that has so successfully led to our improved
understanding in biochemical and physiological systems,
culminating in the medical successes that we enjoy today.
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